Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study

By Athyros Vasilios G.   Mikhailidis Dimitri P.   Papageorgiou Athanasios A.   Bouloukos Vasilios I.   Pehlivanidis Anthimos N.   Symeonidis Athanasios N.   Kakafika Anna I.   Daskalopoulou Stella S.   Elisaf Moses  

Platelets, Vol. 16, Iss. 2, 2005-03 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

Prevention of Coronary Heart Disease in Clinical Practice. Summary of Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

By WOOD DAVID   BACKER GUY DE   FAERGEMAN OLE   GRAHAM IAN   MANCIA GIUSEPPE   PYÖRÄLÄ KALEVI  

Blood Pressure, Vol. 7, Iss. 5-6, 1998-12 ,pp. : 262-269

Informa Healthcare

Access to resources Recommend Favorite

Update of antibiotic trials for secondary prevention of coronary heart disease

By Anderson JL   Muhlestein JB  

Future Cardiology, Vol. 1, Iss. 2, 2005-03 ,pp. : 225-234

Future Medicine

Access to resources Recommend Favorite

Coronary artery disease management with ivabradine in clinical practice

By Pinto Fausto J.  

European Heart Journal Supplements, Vol. 13, Iss. 1, 2011-09 ,pp. : 25-29

Oxford University Press

Access to resources Recommend Favorite

Long-term aspirin for coronary artery disease: are we being deceived by a biased presentation of the evidence?

By Cleland John GF  

Future Cardiology, Vol. 6, Iss. 2, 2010-03 ,pp. : 141-146

Future Medicine

Access to resources Recommend Favorite